- call +1-201-465-4211
- email sales@mrinsights.biz
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is mainly employed to treat mild-to-moderate pain & reduces pain, inflammation, swelling, and stiffness. It is supplied as or contained in medications under a variety of trade names.
Scope of the Report:
This report focuses on the Diclofenac in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
This drug is applicable for inflammatory disorders such as arthritis, rheumatoid arthritis, dermatomyositis, osteoarthritis, dental pain, spondylarthritis, and gout attacks.
The worldwide market for Diclofenac is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Auro Laboratories
Henan Dongtai
Bayer
Pfizer
Hunan Warrant
Novartis
Simcere
Merck
Istituto Biochimico
Metrix Healthcare
Aarti
Kairav Chemicals
Nipa Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Osteoarthritis
Ankylosing Spondylitis
Dysmenorrhea
Rheumatoid Arthritis
Migraine
Pain
Others
Market Segment by Applications, can be divided into
Oral
Parenteral
There are 15 Chapters to deeply display the global Diclofenac market.
Chapter 1, to describe Diclofenac Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Diclofenac, with sales, revenue, and price of Diclofenac, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Diclofenac, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Diclofenac market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Diclofenac sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Diclofenac Introduction
1.2 Market Analysis by Type
1.2.1 Osteoarthritis
1.2.2 Ankylosing Spondylitis
1.2.3 Dysmenorrhea
1.2.4 Rheumatoid Arthritis
1.2.5 Migraine
1.2.6 Pain
1.2.7 Others
1.3 Market Analysis by Applications
1.3.1 Oral
1.3.2 Parenteral
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Auro Laboratories
2.1.1 Business Overview
2.1.2 Diclofenac Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Auro Laboratories Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Henan Dongtai
2.2.1 Business Overview
2.2.2 Diclofenac Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Henan Dongtai Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Diclofenac Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Diclofenac Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hunan Warrant
2.5.1 Business Overview
2.5.2 Diclofenac Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hunan Warrant Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Diclofenac Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Simcere
2.7.1 Business Overview
2.7.2 Diclofenac Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Simcere Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Diclofenac Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Istituto Biochimico
2.9.1 Business Overview
2.9.2 Diclofenac Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Istituto Biochimico Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Metrix Healthcare
2.10.1 Business Overview
2.10.2 Diclofenac Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Metrix Healthcare Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Aarti
2.11.1 Business Overview
2.11.2 Diclofenac Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Aarti Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Kairav Chemicals
2.12.1 Business Overview
2.12.2 Diclofenac Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Kairav Chemicals Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Nipa Pharmaceuticals
2.13.1 Business Overview
2.13.2 Diclofenac Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Nipa Pharmaceuticals Diclofenac Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Diclofenac Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Diclofenac Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Diclofenac Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Diclofenac Manufacturer Market Share in 2017
3.3.2 Top 6 Diclofenac Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Diclofenac Market Analysis by Regions
4.1 Global Diclofenac Sales, Revenue and Market Share by Regions
4.1.1 Global Diclofenac Sales and Market Share by Regions (2013-2018)
4.1.2 Global Diclofenac Revenue and Market Share by Regions (2013-2018)
4.2 North America Diclofenac Sales and Growth Rate (2013-2018)
4.3 Europe Diclofenac Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Diclofenac Sales and Growth Rate (2013-2018)
4.5 South America Diclofenac Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Diclofenac Sales and Growth Rate (2013-2018)
5 North America Diclofenac by Countries
5.1 North America Diclofenac Sales, Revenue and Market Share by Countries
5.1.1 North America Diclofenac Sales and Market Share by Countries (2013-2018)
5.1.2 North America Diclofenac Revenue and Market Share by Countries (2013-2018)
5.2 United States Diclofenac Sales and Growth Rate (2013-2018)
5.3 Canada Diclofenac Sales and Growth Rate (2013-2018)
5.4 Mexico Diclofenac Sales and Growth Rate (2013-2018)
6 Europe Diclofenac by Countries
6.1 Europe Diclofenac Sales, Revenue and Market Share by Countries
6.1.1 Europe Diclofenac Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Diclofenac Revenue and Market Share by Countries (2013-2018)
6.2 Germany Diclofenac Sales and Growth Rate (2013-2018)
6.3 UK Diclofenac Sales and Growth Rate (2013-2018)
6.4 France Diclofenac Sales and Growth Rate (2013-2018)
6.5 Russia Diclofenac Sales and Growth Rate (2013-2018)
6.6 Italy Diclofenac Sales and Growth Rate (2013-2018)
7 Asia-Pacific Diclofenac by Countries
7.1 Asia-Pacific Diclofenac Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Diclofenac Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Diclofenac Revenue and Market Share by Countries (2013-2018)
7.2 China Diclofenac Sales and Growth Rate (2013-2018)
7.3 Japan Diclofenac Sales and Growth Rate (2013-2018)
7.4 Korea Diclofenac Sales and Growth Rate (2013-2018)
7.5 India Diclofenac Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Diclofenac Sales and Growth Rate (2013-2018)
8 South America Diclofenac by Countries
8.1 South America Diclofenac Sales, Revenue and Market Share by Countries
8.1.1 South America Diclofenac Sales and Market Share by Countries (2013-2018)
8.1.2 South America Diclofenac Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Diclofenac Sales and Growth Rate (2013-2018)
8.3 Argentina Diclofenac Sales and Growth Rate (2013-2018)
8.4 Colombia Diclofenac Sales and Growth Rate (2013-2018)
9 Middle East and Africa Diclofenac by Countries
9.1 Middle East and Africa Diclofenac Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Diclofenac Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Diclofenac Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Diclofenac Sales and Growth Rate (2013-2018)
9.3 UAE Diclofenac Sales and Growth Rate (2013-2018)
9.4 Egypt Diclofenac Sales and Growth Rate (2013-2018)
9.5 Nigeria Diclofenac Sales and Growth Rate (2013-2018)
9.6 South Africa Diclofenac Sales and Growth Rate (2013-2018)
10 Global Diclofenac Market Segment by Type
10.1 Global Diclofenac Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Diclofenac Sales and Market Share by Type (2013-2018)
10.1.2 Global Diclofenac Revenue and Market Share by Type (2013-2018)
10.2 Osteoarthritis Sales Growth and Price
10.2.1 Global Osteoarthritis Sales Growth (2013-2018)
10.2.2 Global Osteoarthritis Price (2013-2018)
10.3 Ankylosing Spondylitis Sales Growth and Price
10.3.1 Global Ankylosing Spondylitis Sales Growth (2013-2018)
10.3.2 Global Ankylosing Spondylitis Price (2013-2018)
10.4 Dysmenorrhea Sales Growth and Price
10.4.1 Global Dysmenorrhea Sales Growth (2013-2018)
10.4.2 Global Dysmenorrhea Price (2013-2018)
10.5 Rheumatoid Arthritis Sales Growth and Price
10.5.1 Global Rheumatoid Arthritis Sales Growth (2013-2018)
10.5.2 Global Rheumatoid Arthritis Price (2013-2018)
10.6 Migraine Sales Growth and Price
10.6.1 Global Migraine Sales Growth (2013-2018)
10.6.2 Global Migraine Price (2013-2018)
10.7 Pain Sales Growth and Price
10.7.1 Global Pain Sales Growth (2013-2018)
10.7.2 Global Pain Price (2013-2018)
10.8 Others Sales Growth and Price
10.8.1 Global Others Sales Growth (2013-2018)
10.8.2 Global Others Price (2013-2018)
11 Global Diclofenac Market Segment by Application
11.1 Global Diclofenac Sales Market Share by Application (2013-2018)
11.2 Oral Sales Growth (2013-2018)
11.3 Parenteral Sales Growth (2013-2018)
12 Diclofenac Market Forecast (2018-2023)
12.1 Global Diclofenac Sales, Revenue and Growth Rate (2018-2023)
12.2 Diclofenac Market Forecast by Regions (2018-2023)
12.2.1 North America Diclofenac Market Forecast (2018-2023)
12.2.2 Europe Diclofenac Market Forecast (2018-2023)
12.2.3 Asia-Pacific Diclofenac Market Forecast (2018-2023)
12.2.4 South America Diclofenac Market Forecast (2018-2023)
12.2.5 Middle East and Africa Diclofenac Market Forecast (2018-2023)
12.3 Diclofenac Market Forecast by Type (2018-2023)
12.3.1 Global Diclofenac Sales Forecast by Type (2018-2023)
12.3.2 Global Diclofenac Market Share Forecast by Type (2018-2023)
12.4 Diclofenac Market Forecast by Application (2018-2023)
12.4.1 Global Diclofenac Sales Forecast by Application (2018-2023)
12.4.2 Global Diclofenac Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Diclofenac Picture
Table Product Specifications of Diclofenac
Figure Global Sales Market Share of Diclofenac by Types in 2017
Table Diclofenac Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
